4H-PYRAN-4-ONE
Synonym(s):γ-Pyrone
- CAS NO.:108-97-4
- Empirical Formula: C5H4O2
- Molecular Weight: 96.08
- MDL number: MFCD00006576
- EINECS: 203-634-8
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:11:59
What is 4H-PYRAN-4-ONE?
The Uses of 4H-PYRAN-4-ONE
4H-Pyran-4-one was used in the synthesis of probes grafted on the lipid headgroups.
Definition
ChEBI: A pyranone that is 4H-pyran substituted by an oxo group at position 4.
Preparation
1) from Diethylacetone dioxalate by cyclization to Chelidonic acid (gamma-Pyrone-
2,6-dicarboxylic acid). The acid yields 4H-Pyran-4-one by decarboxylation.
2) by heating of I-Methoxypent-l -en-3-yn-5-
al diethylacetal with Methanol and water,
using Mercuric sulfate or Sulfuric acid
catalyst.
Purification Methods
Purify -pyrone by vacuum distillation; the distillate crystallises and is hygroscopic. It is non-steam vola
Properties of 4H-PYRAN-4-ONE
| Melting point: | 32-34 °C(lit.) |
| Boiling point: | 210-215 °C(lit.) |
| Density | 1.20 |
| refractive index | 1.5238 |
| Flash point: | 214 °F |
| storage temp. | 2-8°C |
| solubility | Slightly soluble in water, soluble in alcohol and oils. |
| form | clear liquid |
| color | Light yellow to Brown |
| Odor | Warm, slight ly pungent, hay-like herbaceous odor of moderate to poor tenacity. |
| BRN | 105293 |
| Stability: | Polymerizes under exposure to air (oxygen) and alkali. Turns darker brown, and its odor fades. |
| CAS DataBase Reference | 108-97-4 |
Safety information for 4H-PYRAN-4-ONE
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H332:Acute toxicity,inhalation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 4H-PYRAN-4-ONE
| InChIKey | CVQUWLDCFXOXEN-UHFFFAOYSA-N |
New Products
Paroxetine Impurity G/Paroxetine Related Compound E 1-Aminocyclopentane carbonitrile (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine(RM for Indian lab) Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate (R)-1-Benzyl-3-pyrrolidinecarbonitrile Betahistine EP Impurity C Cyclobenzaprine N-oxide/Citalopram Related Compound E Chlorthalidone Impurity I Carbamazepine EP Impurity G Sumatriptan Succinate USP Related Compound C 2,2'-(5-methyl-1,3-phenylene)-di(2-Methylpropionitrile) 4-Fluorothiophenol 1-methyl amino-2,4-dinitro benzene 5-Methyl-1,3-benzenediacetonitrile (R)-BoroLeu-(+)-Pinanediol-CF3COOH 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 4-Bromo Benzylcyanide 3-Hydroxypropionitrile valeronitrile 3,4 Dimethoxy Benzylcyanide 3-chlorobenzyl cyanide 2-Chloro BenzylcyanideRelated products of tetrahydrofuran








You may like
-
4H-Pyran-4-one CAS 108-97-4View Details
108-97-4 -
4H-Pyran-4-one CAS 108-97-4View Details
108-97-4 -
2847776-12-7 Sumatriptan Succinate USP Related Compound C NLT 95%View Details
2847776-12-7 -
1012886-75-7(HCl Salt)/69675-10-1(Freebase) Paroxetine Impurity G/Paroxetine Related Compound E NLT 95%View Details
1012886-75-7(HCl Salt)/69675-10-1(Freebase) -
3,4 Diethoxy Benzylcyanide 99%View Details
27472-21-5 -
Bromoacetaldehyde Dimethyl Acetal (stabilized with K2CO3)View Details
7252-83-7 -
157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+View Details
157528-56-8 -
157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+View Details
157528-56-8
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

